Eldecalcitol
| CAS No. | 104121-92-8 | Cat. No. | BCP16568 |
| Name | Eldecalcitol | ||
| Synonyms | ED 71; ED-71; ED71; 2.beta.-(3-Hydroxypropoxy)-1.alpha.,25-dihydroxyvitamin D3; 1,25-dihydroxyvitamin D3; 2-(3-Hydroxypropoxy)calcitriol; Edirol; | ||
| Formula | C30H50O5 | M. Wt | 490.72 |
| Description | Eldecalcitol is a drug used in Japan for the treatment of osteoporosis. It is an analog of vitamin D. Eldecalcitol is an orally administered drug to patients, which binds to vitamin D receptors and binding protein for the goal of achieving greater specificity to bind calcium for its absorption. This greater affinity is 2.7-fold that of the active vitamin D form of calcitriol. Eldecalcitol is readily absorbed into the body, with a long elimination half-life of over eight hours, reaching maximum absorption in 3.4 hours. | ||
| Pathways | Others Pathway | ||
| Targets | Vitamin D Related | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.